Adamas Pharmaceuticals Inc short interest in 2019
In 2019, Adamas Pharmaceuticals Inc's disclosed short interest ran from 24.74% of shares outstanding on 15 Jan 2019 to 8.55% on 31 Dec 2019, a change of -16.19 percentage points. The year's high was 24.74% on 15 Jan 2019 and its low 6.63% on 13 Dec 2019, averaging 16.35% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 28.68 days on 30 Apr 2019. Full history: Adamas Pharmaceuticals Inc.
Cite this page
By year: 2018 · 2019 · 2020 · 2021
2019 in figures
- Start of year
- 24.74% (15 Jan 2019)
- End of year
- 8.55% (31 Dec 2019)
- Change
- -16.19 pp
- High
- 24.74% (15 Jan 2019)
- Low
- 6.63% (13 Dec 2019)
- Average
- 16.35%
- Highest days to cover
- 28.68 (30 Apr 2019)
- SEC filings marked
- 9
Every report in 2019
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2019 | 24.74% | 13.56 | results (8-K) |
| 31 Jan 2019 | 23.46% | 16.58 | |
| 15 Feb 2019 | 19.69% | 10.82 | |
| 28 Feb 2019 | 21.03% | 16.31 | |
| 15 Mar 2019 | 24.60% | 4.99 | 10-K filed, results (8-K) |
| 29 Mar 2019 | 24.37% | 20.87 | |
| 15 Apr 2019 | 22.99% | 12.08 | |
| 30 Apr 2019 | 22.73% | 28.68 | |
| 15 May 2019 | 20.89% | 13.31 | 10-Q filed, results (8-K) |
| 31 May 2019 | 19.30% | 8.82 | |
| 14 Jun 2019 | 18.99% | 23.38 | |
| 28 Jun 2019 | 16.56% | 11.49 | |
| 15 Jul 2019 | 16.65% | 18.66 | |
| 31 Jul 2019 | 13.74% | 13.33 | |
| 15 Aug 2019 | 13.52% | 8.54 | 10-Q filed, results (8-K) |
| 30 Aug 2019 | 10.24% | 8.18 | |
| 13 Sep 2019 | 8.69% | 5.62 | |
| 30 Sep 2019 | 7.23% | 2.01 | |
| 15 Oct 2019 | 11.91% | 3.70 | |
| 31 Oct 2019 | 14.04% | 12.70 | |
| 15 Nov 2019 | 12.67% | 8.95 | 10-Q filed, results (8-K) |
| 29 Nov 2019 | 9.08% | 7.29 | |
| 13 Dec 2019 | 6.63% | 4.16 | |
| 31 Dec 2019 | 8.55% | 1.80 |
See also: Adamas Pharmaceuticals Inc's full history · most shorted US stocks of 2019 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.